Love Babies?

Then Like Babies 411

Last updateTue, 28 Oct 2014 9pm

Back Home Infant News News FDA Warns Against Prolonged Use of Magnesium Sulfate to Stop Pre-term Labor

FDA Warns Against Prolonged Use of Magnesium Sulfate to Stop Pre-term Labor

Pin it

ultrasound of babyThe U.S. Food and Drug Administration (FDA) is advising health care professionals against using magnesium sulfate injection for more than 5-7 days to stop pre-term labor in pregnant women. According to the FDA, administration of magnesium sulfate to pregnant women longer than 5-7 days may lead to low calcium levels and bone problems in the developing baby. Bone issues that can occur include osteopenia (thin bones) and bone fractures.

Due to these new findings, magnesium sulfate has been changed from a Pregnancy A category to a Pregnancy D category. Category D means that there is positive evidence of human fetal risk, but the potential benefits from using the drug in pregnant women may be acceptable in certain situations despite its risks, including to prevent of seizures from preeclampsia and/or eclampsia. Both conditions can be life-threatening.
 
Want to learn more? Read the drug safety communication here.
 

baby logo small
Be sure to like, comment and share Babies 411 content with your friends to help keep babies healthy and safe.
 

FacebookMySpaceTwitterDiggDeliciousStumbleuponGoogle BookmarksRSS Feed